# Allogene Therapeutics, Inc.: Form 8-K, filed Jan 31, 2024

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: 8-K
- Filed: 2024-01-31
- Accepted by EDGAR: Jan 30, 2024, 18:43 ET
- Period: 2024-01-25
- Accession: 0001737287-24-000003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000173728724000003/allo-20240125.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000173728724000003/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000173728724000003/allo-20240125.htm

Filed Jan 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001737287-24-000003. Last ingested by Listed: Nov 5, 2026, 17:19 ET. No prices; not investment advice.